APA (7th ed.) Citation

Zhu, Q., McLellan, J. S., Kallewaard, N. L., Ulbrandt, N. D., Palaszynski, S., Zhang, J., . . . Suzich, J. A. (2017). A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Science translational medicine, 9(388), . https://doi.org/10.1126/scitranslmed.aaj1928

Chicago Style (17th ed.) Citation

Zhu, Qing, et al. "A Highly Potent Extended Half-life Antibody as a Potential RSV Vaccine Surrogate for All Infants." Science Translational Medicine 9, no. 388 (2017). https://doi.org/10.1126/scitranslmed.aaj1928.

MLA (9th ed.) Citation

Zhu, Qing, et al. "A Highly Potent Extended Half-life Antibody as a Potential RSV Vaccine Surrogate for All Infants." Science Translational Medicine, vol. 9, no. 388, 2017, https://doi.org/10.1126/scitranslmed.aaj1928.